Fibrosis with bile duct proliferation in rat liver induced by oral administration of excess glucose-cysteine.
D000818:Animals; D001219:Aspartate Aminotransferases / Q000032:analysis; D001652:Bile Ducts / Q000473:pathology*; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D003545:Cysteine / Q000008:administration & dosage* / Q000378:metabolism; D004906:Erythrocyte Count; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006452:Hemoglobinometry; D007958:Leukocyte Count; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009584:Nitrogen / Q000097:blood; D009929:Organ Size; D010743:Phospholipids / Q000032:analysis; D051381:Rats; D013154:Spleen
D001786:Blood Glucose; D001798:Blood Proteins; D008055:Lipids; D010743:Phospholipids; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D005947:Glucose; D003545:Cysteine; D009584:Nitrogen